GW Pharmaceuticals plc (NASDAQ: GWPH) has seen its stock gain over 17% in the past one month. The company delivered topline growth
GW Pharmaceuticals (GWPH): Investments in manufacturing and international expansion serve as strong growth drivers
Categories
Medical Cannabis
Tilray Inc (NASDAQ: TLRY) Q1 2020 Earnings Call Transcript
Tilray Inc (TLRY) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Raphael Gross -- Investor Relations Brendan Kennedy -- Chief Executive Officer Michael Kruteck -- Chief
GW Pharmaceuticals PLC (NASDAQ: GWPH) Q1 2020 Earnings Call Transcript
GW Pharmaceuticals PLC (GWPH) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Stephen Schultz -- Vice President, Investor Relations Justin Gover -- Chief Executive
New products, global expansion might help Cronos Group beat Covid crisis
The cannabis market, which has been witnessing issues like low demand and the vaping crisis, is probably headed for a slowdown this
Cronos Group Inc. (NASDAQ: CRON) Q1 2020 Earnings Call Transcript
Cronos Group Inc. (CRON) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Shayne Laidlaw -- Investor Relations Mike Gorenstein -- Chairman, President and Chief
Cronos Group (CRON) Q1 profit dips 76% amid continued growth of cannabis
Cronos Group Inc. (NASDAQ: CRON) reported a 76% dip in earnings for the first quarter of 2020 due to higher operating expenses
Aphria Inc (NYSE: APHA) Q3 2020 Earnings Call Transcript
Aphria Inc (APHA) Q3 2020 earnings call dated Apr. 15, 2020 Corporate Participants: Katie M. Turner -- Investor Relations Irwin D. Simon -- Chief Executive Officer Carl
Aphria Inc (NYSE: APHA) Q2 2020 Earnings Call Transcript
Aphria Inc (NYSE: APHA) Q2 2020 Earnings Conference Call January 14, 2020 Corporate Participants: Katie M. Turner -- Managing Director Irwin D. Simon -- Interim Chief Executive
Cronos Group (CRON) swings to a profit in Q4
Cronos Group Inc. (NASDAQ: CRON) swung to a profit in the fourth quarter of 2019 from a loss last year, helped by
HEXO Corp (HEXO) loss in Q2 widens amid impairment charges
HEXO Corp.'s (TSX: HEXO; NYSE: HEXO) loss expanded in the second quarter of 2020, hurt by significant impairment charges. Hexo posted a
Tilray lingers near a yearly low as lack of clarity about pot industry continues
Tilray Inc. (NASDAQ: TLRY) stock is trading near the yearly low on Wednesday after falling over 64% in the year so far
Research Tear Sheet: Village Farms International (VFF) stock
Last year, Canada became the breeding ground for numerous pot stocks following the country’s decision to legalize the use of marijuana for
CannTrust may be cheap, but stay away from this pot stock
Shares of CannTrust Holdings (NYSE: CTST) have plunged over 80% in the past 12 months, making it quite cheap with respect to
Aurora, Canopy Growth to be the biggest gainers in Cannabis 2.0
Both Aurora Cannabis (NYSE: ACB) and Canopy Growth Corporation (NYSE: CGC) have reported disappointing quarterly results in the most recent quarter. Share
Aurora Cannabis stock drops after reporting Q4 results
Aurora Cannabis (NYSE: ACB) reported fourth quarter 2019 results and the topline missed the company's estimates. ACB stock, which closed up 3.34%
What to expect from Aurora Cannabis Q4 earnings
Canadian-based cannabis producer Aurora Cannabis (NYSE: ACB) is slated to report its fourth-quarter results on September 11 after the bell followed by
Pot giants gain on DEA announcement; GW Pharmaceuticals continues to decline
Marijuana giants received a major boost on Monday after the US Drug Enforcement Administration (DEA) announced that it would initiate steps to
WeedMD posts wider loss in Q1 but revenue soars 192%
Medical-grade cannabis producer WeedMD Inc. reported a wider loss in the first quarter of 2019 due to higher costs and expenses despite